Report overview
Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Implants. This report contains market size and forecasts of Cardiovascular Implants in global, including the following market information:
Global Cardiovascular Implants Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cardiovascular Implants Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Cardiovascular Implants companies in 2022 (%)
The global Cardiovascular Implants market was valued at US$ 17880 million in 2022 and is projected to reach US$ 23330 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiovascular Implants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Implants Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cardiovascular Implants Market Segment Percentages, by Type, 2022 (%)
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device
Global Cardiovascular Implants Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cardiovascular Implants Market Segment Percentages, by Application, 2022 (%)
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others
Global Cardiovascular Implants Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cardiovascular Implants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Implants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cardiovascular Implants revenues share in global market, 2022 (%)
Key companies Cardiovascular Implants sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cardiovascular Implants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Boston Scientific
Medtronic
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiovascular Implants, market overview.
Chapter 2: Global Cardiovascular Implants market size in revenue and volume.
Chapter 3: Detailed analysis of Cardiovascular Implants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Implants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cardiovascular Implants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
